Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo(Emory University), Haian Fu(Emory University), Sean P. Doyle(Emory University), Danielle Cicka(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center), Sagar Lonial(Emory University), Lee Cooper(Georgia Institute of Technology), Changfa Shu(Central South University), Kun Qian(University of Georgia), Dacheng Fan(Emory University), Andrei A. Ivanov, Carlos S. Moreno(Emory University), Fadlo R. Khuri(American University of Beirut Medical Center), Matthew A. Reyna(Emory University), Yiu Huen Tsang(Oregon Health & Science University), Cong Tang(Babraham Institute), Wei Zhou(Emory University), Alafate Wahafu(First Affiliated Hospital of Xi'an Jiaotong University), Qianjin Li(Emory University), Suresh S. Ramalingam(Emory University), Qiankun Niu, Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Yuhong Du(Emory University), Xuan Yang(Emory University)
Cited by 75
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k